Followers | 259 |
Posts | 51104 |
Boards Moderated | 18 |
Alias Born | 08/29/2007 |
![](https://investorshub.advfn.com/uicon/108458.png?cb=1482855649)
Tuesday, April 16, 2024 3:53:39 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent VERV News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:07:01 PM
- Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/31/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 11:14:03 AM
- Verve Therapeutics Announces Leadership Update • GlobeNewswire Inc. • 05/31/2024 11:00:00 AM
- Verve Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/30/2024 08:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 11:30:33 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 11:15:11 AM
- Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/08/2024 11:00:00 AM
- Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102 • GlobeNewswire Inc. • 05/07/2024 11:00:00 AM
- Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/03/2024 08:01:00 PM
- Verve Therapeutics Announces Updates on its PCSK9 Program • GlobeNewswire Inc. • 04/02/2024 11:00:00 AM
- Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/28/2024 08:51:34 PM
- Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/01/2024 09:01:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/27/2024 01:32:23 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2024 01:00:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 12:45:10 PM
- Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/27/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:30:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:30:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:30:11 PM
- Verve Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference • GlobeNewswire Inc. • 02/01/2024 11:30:00 AM
- Verve Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/02/2024 11:30:11 AM
- Verve Therapeutics Announces Closing of Public Offering of Common Stock, Full Exercise by Underwriters of Option to Purchase Additional Shares and Closing of Concurrent Private Placement • GlobeNewswire Inc. • 12/01/2023 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:54:53 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/29/2023 09:47:16 PM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM